Azlocillin

N/A

Report date: 2023/01/14 15:50:54

Base Information

Drug NameAzlocillin
Drug Alias NameFP-101FP-101 (Flightpath Biosciences)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell wall inhibitorsBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsLyme Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStanford University
China Registration ClassN/A

Develop Information

Active CompaniesStanford University
Inactive CompaniesN/A
Active IndicationsLyme Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A